In 2025, the FDA issued 470 warning letters; a staggering 99% of these actions cited
The life sciences industry is at a critical inflection point in 2026, as the limitations
How LabVantage LIMS Enables Consistent, Connected, and Context-Rich Scientific Data Artificial intelligence is now integral
Unplanned downtime in a life sciences environment is more than an IT disruption. It creates
In fiscal year 2023, the FDA issued more than 3,800 Form 483 observations, many tied
The next generation of scientific discovery will be defined not by which organizations adopted AI,
How LabWare strengthens the data behind every scientific decision Labs today operate at a scale
Research from the Standish Group indicates that 66% of complex enterprise software implementations fail to
What Private Equity Needs to Know About eClinical Investments Private equity firms evaluating eClinical technology
In this episode, we’re diving into the fascinating world of business processes in IT and
Astrix LIMS Partner Blog with Cloud LIMS - Planning an AI-Driven Lab in 2026? Build
Risk Based Quality Management One Year After ICH E6(R3) The industry is navigating a complex
Type your paragraph here